TY - JOUR T1 - Vitamin D Status and Mortality of German Hemodialysis Patients JF - Anticancer Research JO - Anticancer Res SP - 391 LP - 395 VL - 32 IS - 1 AU - ROLFDIETER KRAUSE AU - HANS-JÜRGEN SCHOBER-HALSTENBERG AU - GÜNTER EDENHARTER AU - KIRSTEN HAAS AU - HEINZ JÜRGEN ROTH AU - ULRICH FREI Y1 - 2012/01/01 UR - http://ar.iiarjournals.org/content/32/1/391.abstract N2 - Aim: The goal was to analyze the link between blood levels of calcidiol and all-cause, cardiac and infectious diseases, and mortality due to cancer in hemodialysis patients. Patients and Methods: This study retrospectively evaluated a representative sub-cohort (n=6,518) of German hemodialysis patients from the incidence cohorts 1997-2006. Results: Most (58.8%) were found to be vitamin D deficient (25(OH)D<20 ng/ml), with 41.2% being severely deficient (25(OH)D<12.5 ng/ml). All-cause mortality risk more than doubled in patients with severe deficiency (adjusted odds ratio (aOR)=2.67; 95% confidence interval (CI)=2.30−3.10; p<0.0001). Comparable data were obtained for mortality from cardiac disease (aOR=1.57; 95% CI=1.30−1.88; p<0.0001), infectious disease (aOR=1.48; 95% CI=1.15−1.90; p=0.0026), and cancer (aOR=1.51; 95% CI=1.09-2.08; p=0.0121), respectively. Conclusion: These data highlight the need to ensure primarily adequate 25(OH)D levels in dialysis patients for an advantage of survival. ER -